Linder MW[au] - Search Results

Year	Number of Results
1983	1
1989	2
1993	1
1994	2
1996	1
1997	1
1998	2
1999	5
2000	2
2001	3
2002	1
2003	2
2004	3
2005	1
2006	2
2007	3
2008	2
2009	1
2012	2
2013	2
2016	3
2017	1
2019	2
2020	2
2021	4
2022	1

1

Cell-free DNA diagnostics: current and emerging applications in oncology.

Muluhngwi P, Valdes R Jr, Fernandez-Botran R, Burton E, Williams B, Linder MW. Muluhngwi P, et al. Among authors: linder mw. Pharmacogenomics. 2019 Apr;20(5):357-380. doi: 10.2217/pgs-2018-0174. Epub 2019 Apr 15. Pharmacogenomics. 2019. PMID: 30983510 Review.

2

Extracellular Vesicles Move Toward Use in Clinical Laboratories.

Strotman LN, Linder MW. Strotman LN, et al. Among authors: linder mw. Clin Lab Med. 2016 Sep;36(3):587-602. doi: 10.1016/j.cll.2016.05.004. Clin Lab Med. 2016. PMID: 27514470 Review.

3

Clinical Utility and Economic Impact of CYP2D6 Genotyping.

Reynolds KK, McNally BA, Linder MW. Reynolds KK, et al. Among authors: linder mw. Clin Lab Med. 2016 Sep;36(3):525-42. doi: 10.1016/j.cll.2016.05.008. Epub 2016 Jun 24. Clin Lab Med. 2016. PMID: 27514466 Review.

4

Current and future challenges in quality assurance in molecular diagnostics.

Ahmad-Nejad P, Ashavaid T, Vacaflores Salinas A, Huggett J, Harris K, Linder MW, Baluchova K, Steimer W, Payne DA; IFCC Committee for Molecular Diagnostics (C-MD). Ahmad-Nejad P, et al. Among authors: linder mw. Clin Chim Acta. 2021 Aug;519:239-246. doi: 10.1016/j.cca.2021.05.004. Epub 2021 May 8. Clin Chim Acta. 2021. PMID: 33971158

5

Liquid Biopsies in Oncology and the Current Regulatory Landscape.

Strotman LN, Millner LM, Valdes R Jr, Linder MW. Strotman LN, et al. Among authors: linder mw. Mol Diagn Ther. 2016 Oct;20(5):429-36. doi: 10.1007/s40291-016-0220-5. Mol Diagn Ther. 2016. PMID: 27324559 Review.

6

Dynamic pharmacogenetic models in anticoagulation therapy.

Bon Homme M, Reynolds KK, Valdes R Jr, Linder MW. Bon Homme M, et al. Among authors: linder mw. Clin Lab Med. 2008 Dec;28(4):539-52. doi: 10.1016/j.cll.2008.10.002. Clin Lab Med. 2008. PMID: 19059061 Review.

7

Polypharmacy: a healthcare conundrum with a pharmacogenetic solution.

Sharp CN, Linder MW, Valdes R Jr. Sharp CN, et al. Among authors: linder mw. Crit Rev Clin Lab Sci. 2019 Nov 2:1-20. doi: 10.1080/10408363.2019.1678568. Online ahead of print. Crit Rev Clin Lab Sci. 2019. PMID: 31680605 Free PMC article.

8

A Shared Diagnostic Stewardship Approach toward Improving Autoimmune Encephalopathy Send-out Testing Utilization.

Sharp CN, Fletcher A, Muluhngwi P, Snyder J, Linder MW, Jortani SA. Sharp CN, et al. Among authors: linder mw. J Appl Lab Med. 2021 Mar 1;6(2):387-396. doi: 10.1093/jalm/jfaa123. J Appl Lab Med. 2021. PMID: 33674881 Free article.

9

Individualizing warfarin therapy.

Reynolds KK, Valdes R Jr, Hartung BR, Linder MW. Reynolds KK, et al. Among authors: linder mw. Per Med. 2007 Feb;4(1):11-31. doi: 10.2217/17410541.4.1.11. Per Med. 2007. PMID: 29793302

10

Longitudinal Relationship between Idylla Plasma ctBRAF V600 Mutation Detection and Tumor Burden in Patients with Metastatic Melanoma.

Linder MW, Egger ME, Van Meter T, Rai SN, Valdes R Jr, Hall MB, Wu X, Alghamdi N, Chesney JA. Linder MW, et al. Mol Diagn Ther. 2021 May;25(3):361-371. doi: 10.1007/s40291-021-00528-4. Epub 2021 May 10. Mol Diagn Ther. 2021. PMID: 33970440 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results